Company: KYIV
Filing Date: 2025-04-18
Form Type: DRS
Source: 0001213900-25-033341
Chunk: 276

Company: Kyivstar Group Ltd.
Filing Date: 2025-04-18
Form: DRS
Chunk 276
---
 generated $24million of revenue in the year ended December 31, 2024. Kyivstar We offer a comprehensive B2B hub and a big data and adtech platform. Our B2B hub offers machine -to -machine(M2M) and cloud solutions, real -timekinematic positioning, cybersecurity services, an M2M SIM management platform and a digital marketplace. As of December 31, 2024, we had 61,000 B2B end users of our workplace cloud service licenses. Adwisor, our adtech platform, is a marketing platform that enables our customers (who are B2B 137 partners, marketers and advertising specialists) to analyze their target audience, find new customers and communicate with current customers. As of December 31, 2024, we had over 1,900 Adwisor contracted customers and for the month ended December 31, 2024, Adwisor supported over 70 million internal and external SMS messages through our network. Helsi In 2022, we acquired a controlling stake in Ukraine’s leading digital health platform, Helsi. Helsi is a digital data management platform supporting the provision of healthcare services by medical institutions and doctors and improving patients’ access to healthcare, including by facilitating remote consultations and appointment bookings and storing medical data. Through this strategic investment, we aimed to extend telemedicine to the Ukrainian population and develop our service as the leading B2B and B2C e -healthprovider in the country. As of December 31, 2024, we had over 28 million registered patients who were able to access 1,600 public and private clinics and over 39,000 medical professionals. In the year ended December 31, 2024, over 9.4 million appointments were conducted via Helsi, generating $5.1million of revenue, compared to 7.8 million appointments and $3.6 million of revenue for the year ended December 31, 2023. Helsi continues to improve access to e -health, focusing on core business development with 5% year -on -yeargrowth of active medical personnel in the Helsi medical information system from approximately 37,500 in 2023 to approximately 39,200 in 2024. Helsi also experienced improved B2C customer engagement through digital channels and the launch of new services, such as AI -poweredinterpretation of laboratory test results, which were activated by over 800